Financials

News Ideas Technicals

268600 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CELLIVERY THERAPEUTICS, INC. operating, investing, and financing activities

268600 free cash flow for Q1 24 is -665.28 M KRW. For 2023, 268600 free cash flow was -8.85 B KRW and operating cash flow was -8.79 B KRW.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—